DrugPatentWatch Database Preview
Degarelix acetate - Generic Drug Details
What are the generic sources for degarelix acetate and what is the scope of degarelix acetate freedom to operate?
Degarelix acetate
is the generic ingredient in one branded drug marketed by Ferring and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Degarelix acetate has one hundred and twenty-six patent family members in thirty-six countries.
One supplier is listed for this compound.
Summary for degarelix acetate
| International Patents: | 126 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 25 |
| Clinical Trials: | 20 |
| Patent Applications: | 11 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for degarelix acetate |
| DailyMed Link: | degarelix acetate at DailyMed |
Synonyms for degarelix acetate
| 214766-78-6 |
| 766D786 |
| 934016-19-0 |
| 934246-14-7 |
| Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2 |
| Acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide |
| AKOS030526717 |
| AN-5181 |
| ASP-3550 |
| ASP3550 |
| BDBM50102450 |
| CHEBI:135961 |
| CHEMBL2028987 |
| CHEMBL415606 |
| CS-5350 |
| D-Alaninamide, N-acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucy |
| D01WYT |
| D08635 |
| D08901 |
| D09400 |
| D0Y7KH |
| DB06699 |
| Degarelix |
| Degarelix (INN/USAN) |
| Degarelix [USAN:INN:BAN] |
| Degarelix acetate (JAN) |
| Degarelix acetate (USAN) |
| Degarelix acetate hydrate |
| Degarelix monoacetate |
| EXT215F4ZU |
| FE 200486 |
| FE-200486 |
| FE-200486 (free base) |
| FE200486 |
| FE200486 (AS ACETATE SALT) |
| Firmagon |
| Firmagon (TN) |
| Gonax |
| GTPL5585 |
| HSDB 7817 |
| HY-16168A |
| N-Acetyl-3-(naphtalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-4-((((4S)-2,6-dioxohexahydropyrimidin-4-yl)carbonyl)amino)-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-leucyl-N(sup 6)-(1-m |
| QC-10170 |
| RL02641 |
| SCHEMBL1397034 |
| SX0XJI3A11 |
| Uglypeptide1 |
| UNII-EXT215F4ZU |
| UNII-SX0XJI3A11 |
| Z-3147 |
US Patents and Regulatory Information for degarelix acetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-001 | Dec 24, 2008 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring | FIRMAGON | degarelix acetate | POWDER;SUBCUTANEOUS | 022201-002 | Dec 24, 2008 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for degarelix acetate
| Country | Document Number | Estimated Expiration |
|---|---|---|
| South Korea | 20150091543 | ➤ Sign Up |
| Slovenia | 2650012 | ➤ Sign Up |
| Denmark | 2249859 | ➤ Sign Up |
| Slovenia | 2505204 | ➤ Sign Up |
| South Africa | 201005697 | ➤ Sign Up |
| Uruguay | 24958 | ➤ Sign Up |
| Croatia | P20150633 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for degarelix acetate
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2 | Finland | ➤ Sign Up | |
| 0395 | Netherlands | ➤ Sign Up | 300395, 20180413, EXPIRES: 20230412 |
| 2009005 | Lithuania | ➤ Sign Up | PRODUCT NAME: DEGARELIXUM ACETAT; REGISTRATION NO/DATE: EU/1/08/504/001, 2009 02 17 EU/1/08/504/002 20090217 |
| 1003774/01 | Switzerland | ➤ Sign Up | PRODUCT NAME: DEGARELIX; REGISTRATION NUMBER/DATE: SWISSMEDIC 59455 12.02.2010 |
| C020/2009 | Ireland | ➤ Sign Up | SPC020/2009: 20091119, EXPIRES: 20230412 |
| 2009 00022 | Denmark | ➤ Sign Up | |
| C/GB09/028 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DEGARELIX OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT SUCH AS THE ACETATE; REGISTERED: UK EU/1/08/504/001 20090217; UK EU/1/08/504/002 20090217 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
